Â
July 16, 2012 — Cardiosolutions Inc., an early-stage company focused on the development of an innovative percutaneous system to treat patients with moderate to severe mitral valve regurgitation, today announced it has received a minority investment from Sorin Group. Sorin is a global medical device company and develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.Â
